-transparent.png){kind=logo}
Sideroblastic anemia after treatment for Hogdkin's disease was seen in two patients 3 years after completion of radiation therapy and chemotherapy. This was followed in both by the development of myelomonoblastic leukemia. No evidence of recurrent Hodgkin's disease was present in either patient. Our observation suggests that development of sideroblastic anemia in patients previously treated for Hodgkin's disease is probably secondary to the treatment and is a preleukemic event.
Related Publications
M Kitahara, and
T M Cosgriff, and
H J Eyre
January 1976,
Medicinski pregled,
M Kitahara, and
T M Cosgriff, and
H J Eyre
January 1973,
Blood,
M Kitahara, and
T M Cosgriff, and
H J Eyre
April 1978,
Archives of internal medicine,
M Kitahara, and
T M Cosgriff, and
H J Eyre
October 2010,
Mymensingh medical journal : MMJ,
M Kitahara, and
T M Cosgriff, and
H J Eyre
April 1992,
Bone marrow transplantation,
M Kitahara, and
T M Cosgriff, and
H J Eyre
May 1972,
Canadian Medical Association journal,
M Kitahara, and
T M Cosgriff, and
H J Eyre
April 1994,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Kitahara, and
T M Cosgriff, and
H J Eyre
July 1974,
Blood,
M Kitahara, and
T M Cosgriff, and
H J Eyre
September 1980,
Human pathology,
M Kitahara, and
T M Cosgriff, and
H J Eyre
July 2019,
La Revue de medecine interne,
